Christiaan de Vries

Christiaan de Vries is a seasoned professional in clinical research and development, currently serving as the Director of Vaccine Clinical Research and Development at Pfizer since December 2024. Prior experience includes a directorial role in Clinical Development at Gilead Sciences from July 2021 to December 2024 and various academic positions at Stanford University School of Medicine from July 2017 to December 2023, including Adjunct Clinical Assistant Professor and Fellow in Infectious Diseases. Previous roles also encompass Medical Director at Karius and Resident Physician at the Icahn School of Medicine at Mount Sinai. Christiaan de Vries began a career in research as a Research Technician at the National Cancer Institute from June 2004 to May 2007. Educational qualifications include a Doctor of Medicine from Rutgers Robert Wood Johnson Medical School, a Doctor of Philosophy in Molecular Biosciences from Rutgers University–New Brunswick, and a Bachelor of Arts in Biological Sciences from the same institution.